# LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

> **NCT06788002** · PHASE2 · RECRUITING · sponsor: **Hunan Cancer Hospital** · enrollment: 26 (estimated)

## Conditions studied

- Nasopharyngeal Cancinoma (NPC)

## Interventions

- **OTHER:** Low-dose radiotherapy combine with chemoimmunotherapy

## Key facts

- **NCT ID:** NCT06788002
- **Lead sponsor:** Hunan Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-14
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788002, "LDRT and Chemoimmunotherapy in NPC With Liver Metastasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06788002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*